GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Synonyms: Example 69 [WO2022208391A1]
Compound class:
Synthetic organic
Comment: Polfurmetinib is the INN for a MEK tyrosine kinase inhibitor with antineoplastic potential, from INN proposed list 133 (10th July 2025). The structure is claimed as Example 69 in Pfizer patent WO2022208391A1 [1]. Pfizer have a brain-penetrant MEK inhibitor (PF-07799544) in clinical development, but its structure has not been disclosed (August 2025).
|
|
References |
1. Allen S, Blake JF, Blanche ST, Boys ML, Clark WD, Cowdrey CJ, Dahlke JR, Barbour PMD, Kellum AA, KnappEM et al.. (2022)
3,4-dihydro-2,7-naphthyridine-1,6(2h,7h)-diones as MEK inhibitors. Patent number: WO2022208391A1. Assignee: Pfizer Inc,. Priority date: 30/03/2022. Publication date: 06/10/2022. |